Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-02-14 4:03 pm Sale | 13G | PIERIS PHARMACEUTICALS INC PIRS | BIOTECHNOLOGY VALUE FUND L P | 5,506,905 9.99% | -1,951,016 (-26.16%) | View |
2020-02-14 3:59 pm Purchase | 13G | BIOLINERX LTD SPONSORED ADR NE BLRX | BIOTECHNOLOGY VALUE FUND L P | 31,942,380 17.5% | 31,942,380 (New Position) | View |
2020-02-14 3:29 pm Purchase | 13G | XENON PHARMACEUTICALS INC XENE | BIOTECHNOLOGY VALUE FUND L P | 2,656,057 9.99% | 53,221 (+2.04%) | View |
2020-02-14 3:26 pm Purchase | 13G | PRINCIPIA BIOPHARMA INC PRNB | BIOTECHNOLOGY VALUE FUND L P | 1,716,734 5.2% | 79,884 (+4.88%) | View |
2020-02-14 3:25 pm Unchanged | 13G | SPRING BK PHARMACEUTICALS INC SBPH | BIOTECHNOLOGY VALUE FUND L P | 951,701 5.8% | 0 (Unchanged) | View |
2020-02-14 3:21 pm Purchase | 13G | MOLECULAR TEMPLATES INC MTEM | BIOTECHNOLOGY VALUE FUND L P | 3,608,332 8.2% | 243,911 (+7.25%) | View |
2020-02-14 3:21 pm Sale | 13G | VBI VACCINES, INC. VBIV | BIOTECHNOLOGY VALUE FUND L P | 0 0% | -5,216,857 (Position Closed) | View |
2020-02-14 3:18 pm Sale | 13G | GALMED PHARMACEUTICALS LTD. SH GLMD | BIOTECHNOLOGY VALUE FUND L P | 1,832,484 8.7% | -46,024 (-2.45%) | View |
2020-02-14 3:17 pm Sale | 13G | MERRIMACK PHARMACEUTICALS INC MACK | BIOTECHNOLOGY VALUE FUND L P | 0 0% | -721,935 (Position Closed) | View |
2020-02-14 3:14 pm Purchase | 13G | VERASTEM, INC. VSTM | BIOTECHNOLOGY VALUE FUND L P | 6,328,994 8.5% | 816,000 (+14.80%) | View |
2020-02-14 3:13 pm Sale | 13G | CONCERT PHARMACEUTICALS INC CO CNCE | BIOTECHNOLOGY VALUE FUND L P | 0 0% | -1,408,187 (Position Closed) | View |
2020-02-14 3:10 pm Unchanged | 13G | GLYCOMIMETICS INC GLYC | BIOTECHNOLOGY VALUE FUND L P | 7,361,801 17% | 0 (Unchanged) | View |
2020-02-14 3:09 pm Sale | 13G | CHEMOCENTRYX INC CCXI | BIOTECHNOLOGY VALUE FUND L P | 0 0% | -4,105,215 (Position Closed) | View |
2020-02-14 3:07 pm Purchase | 13G | AC IMMUNE SA SHS ACIU | BIOTECHNOLOGY VALUE FUND L P | 11,342,505 16.8% | 44,594 (+0.39%) | View |
2020-02-14 3:05 pm Purchase | 13G | SPRINGWORKS THERAPEUTICS INC C SWTX | BIOTECHNOLOGY VALUE FUND L P | 3,079,155 7.2% | 235,310 (+8.27%) | View |
2020-02-14 3:03 pm Sale | 13G | MERUS N V COM MRUS | BIOTECHNOLOGY VALUE FUND L P | 3,169,654 11% | -173,759 (-5.20%) | View |
2020-02-14 3:00 pm Purchase | 13G | CYTOKINETICS INC CYTK | BIOTECHNOLOGY VALUE FUND L P | 7,206,458 12.2% | 3,055,819 (+73.62%) | View |
2020-02-14 2:59 pm Purchase | 13G | ARCUS BIOSCIENCES INC RCUS | BIOTECHNOLOGY VALUE FUND L P | 3,579,023 7.8% | 1,167,400 (+48.41%) | View |
2020-02-14 2:56 pm Purchase | 13G | FORWARD PHARMA A/S SPONSORED A FWP | BIOTECHNOLOGY VALUE FUND L P | 14,092,736 14.8% | 14,092,736 (New Position) | View |
2020-02-14 2:56 pm Purchase | 13G | BRICKELL BIOTECH INC BBI | BIOTECHNOLOGY VALUE FUND L P | 664,079 8.3% | 664,079 (New Position) | View |